Both miRNAs have a crucial role in hemotoxicity: miRNA-1246 is upregulated to activate the expression of C6orf211 and C19orf10 to promote tumor progression [51], and miR-224 is impaired in the marrow of pediatric AML patients [52]. This evidence concerns the gene MYDGF and neoplasm.